Clin2
NCT07327359Possibly a fitRecruiting

Hair loss treatment for men with male pattern baldness

Androgenetic Alopecia (AGA)

Part of Skin clinical trials.

This study tests a new investigational drug, OLX72021, given as injections into the scalp, to see if it can help regrow hair in men with male pattern baldness. It will also check how safe the drug is and how well it works.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
158 people
Ages
18 years to 59 years
Study type
Interventional

Who can take part

  • You must be a male aged 18 to 59 years.
  • You should have male pattern baldness (specifically a Hamilton-Norwood type 3 vertex, 4, or 5).
  • You must be a non-smoker and in generally good health.
  • You need to be willing to get multiple injections in your scalp and attend all study visits.
  • You must not have used certain hair treatments (like minoxidil, finasteride, or hair transplants) in the recent past or during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07317544Recruiting· Phase 1/Phase 2
ABS-201 trial for hair loss in healthy adults

This trial tests a new medicine (ABS-201) in healthy people to see if it is safe and works for hair loss. It involves multiple doses and compares results based on whether you have the common type of hair loss called androgenetic alopecia.

Sydney, New South Wales
NCT06622824Not yet recruiting· Phase 2/Phase 3
Study of a new scalp solution for male hair loss

This study tests a new scalp solution (KX-826) for men with androgenetic alopecia, commonly known as male pattern baldness. It aims to see if the solution can help regrow hair and is safe to use. Participants will apply the solution to their scalp and have their hair growth monitored over time.

Beijing
NCT07603544Recruiting
Hair Loss Study: Understanding Male Pattern Baldness

This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.

Xinxiang, Henan
NCT07529977Not yet recruiting· Phase 3
Oral minoxidil pill for male hair loss

This study tests an oral pill form of minoxidil, a common hair growth treatment, for men with male pattern baldness. It aims to see if the pill is safe and effective in helping hair regrow.

NCT07693244Recruiting· Phase 2
Exosome therapy for male pattern baldness

This trial tests a new treatment using exosomes (tiny particles that help cells communicate) for male pattern baldness. It may help regrow hair or slow further loss.

Beijing
NCT06764329Enrolling by invitation· Phase 1/Phase 2
Stem cell therapy for male hair loss

This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.

Rawalpindi

Hear when a new Androgenetic Alopecia (AGA) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.